Our MYCN integrative omic analysis revealed a host of known genes, pathways and drugs that were previously associated with neuroblastoma, including p53, TGFβ, TNF, IFNG, Retinoic Acid and epigenetic modifiers [12, 22, 24, 48, 49]. Here, MYCN is linked to neuroblastoma.